Abstract
The intestinal microbiota is vital for shaping the local intestinal environment as well as host immunity and metabolism. At the same time, epidemiological and experimental evidence suggest an important role for parasitic worm infections in maintaining the inflammatory and regulatory balance of the immune system. In line with this, the prevalence of persistent worm infections is inversely correlated with the incidence of immune-associated diseases, prompting the use of controlled parasite infections for therapeutic purposes. Despite this, the impact of parasite infection on the intestinal microbiota, as well as potential downstream effects on the immune system, remain largely unknown. We have assessed the influence of chronic infection with the large-intestinal nematode Trichuris muris, a close relative of the human pathogen Trichuris trichiura, on the composition of the murine intestinal microbiota by 16S ribosomal-RNA gene-based sequencing. Our results demonstrate that persistent T. muris infection dramatically affects the large-intestinal microbiota, most notably with a drop in the diversity of bacterial communities, as well as a marked increase in the relative abundance of the Lactobacillus genus. In parallel, chronic T. muris infection resulted in a significant shift in the balance between regulatory and inflammatory T cells in the intestinal adaptive immune system, in favour of inflammatory cells. Together, these data demonstrate that chronic parasite infection strongly influences the intestinal microbiota and the adaptive immune system. Our results illustrate the complex interactions between these factors in the intestinal tract, and contribute to furthering the understanding of this interplay, which is of crucial importance considering that 500 million people globally are suffering from these infections and their potential use for therapeutic purposes.
Introduction
The gastrointestinal tract harbours a myriad of microorganisms, collectively termed the microbiota, which have evolved complex interdependent relationships with the host[1, 2]. The microbiota is critical to the health of the host by metabolising nutrients[3, 4], maturing the immune system[5–7] and competing out pathogens[8, 9], as evidenced by studies utilising mice raised under germ free conditions devoid of commensal organisms. Thus, resident bacteria shape the host immune system and small disturbances in the balance between different microbial communities can have adverse effects on its integrity. Likewise, activation of the immune system, for example during infection, may lead to alterations in the composition of the microbiota[10, 11], and thereby affect the balance of the intestinal microenvironment. An imbalance in this host-microbial relationship is thought to contribute to multiple inflammatory and autoimmune diseases[6, 12].
Parasitic worms are among the most prevalent pathogens that afflict humans, and they share a long evolutionary history with us. Hence, worm infections are rarely lethal but can nonetheless cause a wide variety of health issues such as abdominal pain, anaemia, stunted growth and impaired cognitive development[13, 14]. On the other hand, parasites may incur benefits to the host by educating the immune system early in life and providing signals that serve to dampen inflammation and strengthen the regulatory immune response[15]. Signs of this may be seen in developed countries, where the absence of worm infections has been correlated with an increased incidence of various immune-associated diseases including allergies, inflammatory bowel disease (IBD), multiple sclerosis, rheumatoid arthritis (RA) and type 1 diabetes (T1D)[16–18]. Encouraged by results from various laboratory models[19–24], much emphasis has been placed on the potential therapeutic value of parasitic infections in treating human diseases[25–28]. Indeed, therapeutic infection with the porcine nematode Trichuris suis is currently in clinical trial for treatment of IBD[29]. Interestingly, diseases that have been associated with the absence of parasitic worms, including IBD, RA and T1D, have also been correlated with alterations in the intestinal microbiota[30]. It is therefore plausible that the lack of parasitic worm infections, via modulation of the intestinal microbiota, might confer protection against these disorders.
Trichuris muris is the murine-specific counterpart to the human pathogen Trichuris trichiura that infects approximately 500 million people globally[31]. Its life cycle follows a strict faecal-oral route. Thus, following infection of the large intestine, T. muris worms remain in the caecal and colonic epithelium throughout their lifespan. During the first three weeks after hatching, the larvae reside embedded in syncytial tunnels formed through adjacent intestinal epithelial cells, but from the L2-L3 moulting stage, worms start protruding out into the intestinal lumen, reaching adulthood five weeks after infection. In line with other intestinal parasites, protective immunity to T. muris infection is dependent on induction of a T helper cell type 2 (Th2) response[32]. However, at sufficiently low doses, T. muris establishes a chronic infection by invoking a Th1 response characterised by the production of the cytokine interferon-γ (IFN-γ)[33].
Given that T. muris larvae occupy the same niche as the majority of the intestinal microbiota it is plausible that these organisms influence each other, which may subsequently affect the intestinal microenvironment of the host. Interestingly, oral administration of Lactobacillus casei can increase the susceptibility to T. muris infections[34] and intestinal luminal bacteria are important for enabling the T. muris larvae to hatch during the initial infection[35], further illustrating the complex inter-species relationships that characterise the intestinal microenvironment. However, data on the influence of Trichuris parasites on intestinal bacterial communities is limited. Studies in pigs infected with T. suis have demonstrated changes in bacterial diversity and metabolic networks after infection[36, 37], whereas studies in humans infected with T. trichiura have yielded conflicting data[38, 39], emphasising the need for further research.
We set out to study the effect of chronic T. muris infection on the gut microbiota and immune response. Here, we provide evidence that persistent T. muris infection resulted in dramatic alterations in microbial communities, in both the caecum and colon, which became apparent approximately three weeks after infection and became increasingly established with time. Overall, these changes resulted in a less diverse microbiota, and were characterised by a marked increase in the relative abundance of the bacterial family Lactobacillaceae. In addition, chronic T. muris infection affected the balance between inflammatory and regulatory immune cells in the intestinal mucosa, although this seemed to occur prior to the increase in Lactobacillaceae. These findings highlight the importance of understanding the intricate interactions of the microbiota, particularly with regard to parasitic worm infections, and their contribution to health and disease.
Materials and Methods
Mice
Mice were obtained from Harlan Laboratories (An Venray, Netherlands). Experiments were conducted with age-matched, male C57BL/6 mice that were eight weeks old at the start of the experimentation. Mice were sacrificed by cervical dislocation.
Ethics Statement
All experiments were conducted in strict accordance with animal welfare laws, as determined by Swedish authorities (Swedish Board of Agriculture, Act 1988:534). The protocol was approved by Malmö/Lund Ethical Board for Animal Research, Lund/Malmö, Sweden (permit no. M467-12), and all efforts were made to minimize suffering of the mice. Mice were monitored daily for signs of stress or disease, such as condition of fur and general movement. None of the mice developed diarrhoea or other intestinal-related issues.
Trichuris muris
T. muris (strain E) was maintained, and worm-derived excretory/secretory (E/S) antigens were generated and purified as previously described[40]. To obtain a chronic T. muris infection, mice were infected with a low dose of approximately twenty infective eggs in sterile-filtered (0.2 μm) tap water by oral gavage. To assess the worm burden of infected mice, large intestines were excised and frozen at -20°C. During the analysis, intestines were cut longitudinally, and scraped free of worms, which were subsequently counted under a reverse phase-contrast microscope.
Experimental Outline
Mice were co-housed for at least two weeks prior to experimentation to ensure normalisation of their microbiota, and were subsequently placed in individual cages during experiments to avoid cross-contamination. Experiments were conducted according to the scheme in S1 Fig 10 mice were infected at day 0 with a low dose T. muris eggs and 20 mice were left uninfected. 10 of the uninfected were sacrificed at day 0 while the remaining 10 were sampled over a 35 days period alongside with the 10 infected mice. Fresh faeces were sampled regularly throughout the experiment, after each larval moulting stage: L2 (day 13), L3 (day 20) and L4 (day 27). The faecal samples were immediately frozen on dry ice upon collection. At the end point (day 35), luminal contents were collected from both the caecum and colon. We sampled the luminal colon content distally, to make them correspond to the fresh faeces samples. For simplicity, luminal colon content sampled upon termination and fresh faeces sampled throughout the infection are collectively referred to as “faecal samples”. Finally, to ensure that mice had been properly infected, a separate group of five mice was infected and sacrificed at day 35 for assessment of their worm burden.
Cell Isolation
Mesenteric lymph nodes (MLN) were stripped of surrounding adipose tissue and mashed in Dulbecco’s phosphate-buffered saline (DPBS; Life Technologies), followed by filtration through 70 μm cell strainers (Fisher Scientific). The large intestines were stripped of attached adipose tissue, opened longitudinally and washed thoroughly in DPBS to remove the faeces. To isolate cells from the large-intestinal lamina propria (LI LP) the intestines were cut into approximately one cm pieces, and incubated thrice in epithelial dissociation buffer consisting of Hank’s balanced salt solution (HBSS; Life Technologies) supplemented with 15 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Life Technologies), 2% foetal bovine serum (FBS; Sigma-Aldrich), 5 mM ethylenediaminetetraacetic acid (EDTA; Merck-Millipore), 100 U/ml penicillin + 100 μg/ml streptomycin (Life Technologies), 50 μg/ml gentamicin (Life Technologies) and 1.25 μg/ml Fungizone (Life Technologies) for 15 minutes at 37°C, on continuous shaking. For the first round of treatment, 1 mM DL-dithiothreitol (DTT; Sigma-Aldrich) was added to aid the removal of mucous. After a brief wash, the remaining tissue pieces were subsequently enzymatically digested in R10 buffer consisting of RPMI 1640 (Life Technologies) supplemented with 10 mM HEPES, 10% FBS, 2 mM L-glutamine (Life Technologies), 1 mM sodium pyruvate (Life Technologies), 100 U/ml penicillin + 100 μg/ml streptomycin, 50 μg/ml gentamicin and 1.25 μg/ml Fungizone, along with 0.3 Wünsch-units/ml liberase TM (Roche), 30 μg/ml DNase I (Roche) and 5 mM CaCl2 for 45 minutes at 37°C with magnetic stirring. The resulting cell suspension was filtered through 100 μm cell strainers (Fisher Scientific), and subjected to a density gradient centrifugation using Percoll (GE Healthcare) according to manufacturer’s instructions. Briefly, cells were suspended in 40% Percoll and centrifuged over a 70% Percoll layer for 20 minutes, 600 g without brake at room temperature. Cells were collected from the 40/70 interphase and washed with R10 buffer. Cell numbers were assessed with a KX-21N automated hematology analyzer (Sysmex).
Ex vivo Cell Stimulations and Cytokine Analyses
For cytokine secretion analyses, cells were suspended in R10 buffer, seeded at 2.5 x 106 cells/ml in TC MicroWell 96U Nunclon plates (Thermo Fisher Scientific), and incubated with 50 μg/ml E/S antigens for 48 hours at 37°C, 5% CO2. Cell-free supernatants were collected and frozen at -20°C for subsequent analyses. Cytokine secretion was measured with BD cytometric bead array (BD Biosciences) according to manufacturer’s instructions with the following modification: the amount of capture beads and detection reagents as well as sample volumes was scaled down five-fold. Samples were acquired on a BD LSR II flow cytometer (BD Biosciences) and data analysed with FCAP Array v3.0 (SoftFlow Inc.).
For intracellular cytokine analyses, cells were suspended in R10 buffer, seeded at 5 x 106 cells/ml in 5 ml polystyrene round-bottom tubes (BD Falcon), and incubated with 250 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich), 500 ng/ml ionomycin (Sigma-Aldrich) and 10 μg/ml brefeldin A (Sigma-Aldrich), or brefeldin A alone as a negative control, for 3 hours at 37°C, 5% CO2. Cells were then washed with R10 buffer followed by staining for flow cytometry analysis.
Flow Cytometry
Cells were fluorescently labelled for 30–60 minutes on ice with the following antibodies and reagents: BV510-conjugated rat anti-mouse CD45 (clone 30-F11; BioLegend), BV605-conjugated Armenian hamster anti-mouse TCRβ (H57-597; BD Biosciences), PE-conjugated rat anti-mouse IL-10 (JES5-16E3; eBioscience), PE-CF594-conjugated rat anti-mouse CD4 (RM4-5; BD Biosciences), PerCP-Cy5.5-conjugated mouse anti-human/mouse T-bet (4B10; eBioscience), PE-Cy7-conjugated rat anti-mouse IFN-γ (XMG1.2; BioLegend), APC-conjugated rat anti-mouse/rat FoxP3 (FJK-16s; eBioscience), AF700-conjugated rat anti-mouse CD19 (6D5; BioLegend), AF700-conjugated rat anti-human/mouse B220 (RA3-6B2; eBioscience), AF700-conjugated mouse anti-mouse NK1.1 (PK136; BioLegend), AF700-conjugated rat anti-mouse Ter-119 (TER-119; BioLegend), biotin-conjugated rat anti-mouse CD8α (53–6.7; BioLegend), APC-eF780-conjugated streptavidin (eBioscience), along with Violet Live/Dead (Life Technologies) according to manufacturer’s instructions to label dead cells. Cells were stained intracellularly with FoxP3/Transcription factor staining buffer set (eBioscience) according to manufacturer’s instructions. Cells were analysed on a BD LSR II flow cytometer, and data analysed with FlowJo software v9.7 (Tree Star Inc.). Dead cells and aggregates were excluded from all analyses.
Amplicon Sequencing
Bacterial DNA from caecal and faecal samples were extracted using a NucleoSpin soil kit (Macherey-Nagel) according to manufacturer’s instructions. DNA yield and integrity were assessed using a Nanodrop and agarose gel electrophoresis, respectively. The PCR-based library formation was performed using 10 ng bacterial DNA, 0.2 μM of each barcoded forward and reverse primer, 0.2 mM dNTPs and 0.5 units Phusion high fidelity DNA polymerase (Thermo Scientific) in a total volume of 25 μl. To target the 16S rRNA gene’s variable region 4 (V4) a forward primer 515F (5’ AATGATACGGCGACCACCGAGATCTACAC NNNNNNNN TATGGTAATTGTGTGCCAGCMGCCGCGGTAA 3’; “N” indicates the nucleotides of the barcode sequence) and a reverse primer 806R (5’ CAAGCAGAAGACGGCATACGAGAT NNNNNNNNNNNN AGTCAGTCAG CC GGACTACHVGGGTWTCTAAT 3’) were used, both with Illumina adaptor sequences in the 5’ end [41, 42]. Cycling condition was as follows: 98°C for 30 seconds followed by 35 cycles of 98°C for 5 s, 56°C for 20 s and 70°C for 20 s. PCR products were purified and normalised to 1–2 ng/μl using the SequalPrep Normalisation Plate kit (Life Technologies Europe). Subsequently, samples were pooled (2 μl of each sample) and quantified using a KAPA Library Quantification Kit (KAPA Biosystems) on a Stratagene Mx3000 (Agilent Technologies Denmark). 6.65 pM library and 0.35 pM PhiX Control v3 (Illumina) was sequenced using an Illumina MiSeq V2 PE500 cartridge (500 cycles) on an Illumina MiSeq.
Bioinformatics
Generated sequences were analysed using qiime_pipe (https://github.com/maasha/qiime_pipe) using QIIME v1.7.0 with default settings, which performs quality-based sequence trimming, primer removal and assembly of paired-end sequences followed by the execution of a QIIME workflow including chimera checking[41]. De novo OTU-picking was performed using UCLUST[43] with 97% sequence similarity. Representative sequences were assigned taxonomy against the Greengenes database v11_2[44] using the RDP-classifier[45] with an 80% confidence threshold. Subsequent analyses were performed in R v3.1.1 using the metagenomeSeq[46], PhyloSeq[47], Vegan[48] and GGplot2[49] packages. Data was filtered for low-abundance OTUs by removal of OTUs present in fewer than 3 of the 140 samples and with a relative abundance across all samples ≤0.005%. A single day 35 faecal sample from one of the infected mice and a single day 0 caecal sample from one of the uninfected mice were left out due to our cut off of at least 10,000 sequences per sample after filtering. Analyses in R were performed with an average of 25,060 ± 6,480 (SD) sequences per sample before, and with 20,912 ± 5,091 (SD) sequences per sample after filtering. Alpha and gamma diversity were estimated using unfiltered data. Beta diversity was performed using filtered data and calculated for time point/treatment using Vegan. Read counts were normalised with metagenomeSeq[46] that uses a cumulative-sum scaling in which raw counts are divided by the cumulative sum of counts up to a particular quantile. Statistical analyses for Table 1 and S2 Table comparing uninfected with infected were performed on data filtered based on effective sample sizes. Taxa were not included if they had fewer than X effective number of positive samples, where X is the median of estimated effective samples per feature calculated using metagenomeSeq. Phylogenetic analyses were conducted using 16S rRNA gene sequences from the given family downloaded from The Ribosomal Database Project (RDP)[50]. The representative sequences, from the OTUs classified to be members of the given family were combined with the RDP sequences. Sequence-alignment using MUSCLE[51] and phylogenetic tree building using the Maximum Likelihood method based on the Tamura-Nei model[52] were performed using MEGA v6.06[50]. All sequence data is available from the European Nucleotide Archive (ENA) with study accession number: PRJEB6560. Immunological raw data is available from Dryad Digital Repository (doi:10.5061/dryad.md0vg).
Table 1. Bacterial taxa that differed significantly within faecal samples after T. muris infection.
Prevalence | Counts | Abundance (%) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Time after infection | Phylum | Class | Order | Family | Genus | Uninfected | Infected | Uninfected | Infected | Uninfected | SEM | Infected | SEM | Adj. P-value |
13 days | Actinobacteria | Actinobacteria | Bifidobacteriaceae | Bifidobacteriaceae | Bifidobacteriumᛏ | 8/10 | 10/10 | 1674 | 2663 | 0.66 | 0.36 | 0.88 | 0.56 | 4.6E-02 |
20 days | Firmicutes | Bacilliᛏ | 10/10 | 10/10 | 3334 | 11805 | 1.65 | 0.24 | 4.49 | 0.83 | 4.1E-02 | |||
Lactobacillalesᛏ | 10/10 | 10/10 | 3325 | 11784 | 1.64 | 0.24 | 4.48 | 0.83 | 3.9E-02 | |||||
Lactobacillaceaeᛏ | 10/10 | 10/10 | 3316 | 11676 | 1.64 | 0.24 | 4.44 | 0.83 | 4.0E-02 | |||||
Lactobacillusᛏ | 10/10 | 10/10 | 3303 | 11638 | 1.63 | 0.24 | 4.43 | 0.83 | 3.1E-02 | |||||
Proteobacteria | Deltaproteobacteriaᛎ | 10/10 | 10/10 | 1820 | 1020 | 0.89 | 0.12 | 0.40 | 0.06 | 3.4E-02 | ||||
Desulfovibrionalesᛎ | 10/10 | 10/10 | 1820 | 1020 | 0.89 | 0.12 | 0.40 | 0.06 | 4.4E-02 | |||||
Desulfovibrionaceaeᛎ | 10/10 | 10/10 | 1803 | 1008 | 0.88 | 0.11 | 0.40 | 0.06 | 4.0E-02 | |||||
Bacteroidetes | Bacteroidia | Bacteriodales | Rikenellaceaeᛏ | 10/10 | 10/10 | 2845 | 8318 | 1.45 | 0.20 | 3.15 | 0.55 | 2.7E-02 | ||
Alistipesᛏ | 10/10 | 10/10 | 2832 | 8280 | 1.45 | 0.20 | 3.13 | 0.55 | 2.0E-02 | |||||
Porphyromonadaceae | Parabacteroidesᛎ | 9/10 | 7/10 | 95 | 30 | 0.05 | 0.01 | 0.01 | 0.00 | 4.7E-02 | ||||
Odirobacterᛏ | 10/10 | 10/10 | 3218 | 11353 | 1.61 | 0.31 | 4.35 | 0.98 | 2.2E-02 | |||||
27 days | Firmicutes | Erysipelotrichiᛏ | 10/10 | 10/10 | 9197 | 11665 | 4.78 | 1.84 | 5.10 | 3.48 | 4.0E-03 | |||
Bacilliᛏ | 10/10 | 10/10 | 2840 | 28576 | 1.32 | 0.16 | 11.41 | 3.12 | 4.0E-03 | |||||
Lactobacillalesᛏ | 10/10 | 10/10 | 2793 | 28565 | 1.30 | 0.15 | 11.40 | 3.12 | 6.8E-03 | |||||
Lactobacillaceaeᛏ | 10/10 | 10/10 | 2790 | 28543 | 1.30 | 0.15 | 11.39 | 3.12 | 2.0E-04 | |||||
Lactobacillusᛏ | 10/10 | 10/10 | 2790 | 28433 | 1.30 | 0.15 | 11.35 | 3.11 | 7.0E-04 | |||||
Clostridia | Clostridiales | Ruminococcaceaeᛎ | 10/10 | 10/10 | 5769 | 4295 | 2.57 | 0.30 | 1.78 | 0.46 | 1.7E-02 | |||
Bacteroidetes | Becteroidia | Bacteroidales | Porphyromonadaceae | Barnesiellaᛎ | 10/10 | 10/10 | 2865 | 1416 | 1.39 | 0.20 | 0.63 | 0.19 | 4.0E-02 | |
35 days | Firmicutes | Bacilliᛏ | 10/10 | 9/9 | 1801 | 29309 | 0.94 | 0.25 | 14.84 | 3.41 | 6.6E-05 | |||
Lactobacillalesᛏ | 10/10 | 9/9 | 1795 | 29297 | 0.93 | 0.25 | 14.84 | 3.41 | 3.5E-04 | |||||
Lactobacillaceaeᛏ | 10/10 | 9/9 | 1785 | 29123 | 0.93 | 0.24 | 14.74 | 3.38 | 6.1E-04 | |||||
Lactobacillusᛏ | 10/10 | 9/9 | 1782 | 28935 | 0.93 | 0.24 | 14.65 | 3.36 | 2.1E-05 | |||||
Erysipelotrichiᛎ | 10/10 | 9/9 | 10924 | 5944 | 5.62 | 1.38 | 2.92 | 1.73 | 6.6E-05 | |||||
Erysipelotrichalesᛎ | 10/10 | 9/9 | 10924 | 5944 | 5.62 | 1.38 | 2.92 | 1.73 | 3.5E-04 | |||||
Erysipelotrichaceaeᛎ | 10/10 | 9/9 | 10924 | 5944 | 5.62 | 1.38 | 2.92 | 1.73 | 8.4E-05 | |||||
Allobaculumᛎ | 10/10 | 9/9 | 10804 | 5892 | 5.56 | 1.38 | 2.90 | 1.72 | 2.8E-03 | |||||
Clostridia | Clostridiales | Lachnospiraceae | Roseburiaᛎ | 10/10 | 6/9 | 163 | 16 | 0.08 | 0.03 | 0.01 | 0.00 | 1.5E-02 | ||
Ruminococcaceae | Oscillibacterᛏ | 10/10 | 8/9 | 1611 | 526 | 0.85 | 0.16 | 0.25 | 0.08 | 1.5E-02 | ||||
Butyricicoccusᛏ | 10/10 | 7/9 | 55 | 131 | 0.03 | 0.01 | 0.06 | 0.03 | 2.5E-02 | |||||
Proteobacteria | Burkholderiales | Burkholderiales | Alcaligenaceae | Parasutterellaᛏ | 10/10 | 9/9 | 1440 | 9032 | 0.71 | 0.16 | 4.30 | 1.75 | 1.6E-02 | |
Alphaproteobacteria | Sphingomonadales | Sphingomonadaceae | Sphingomonasᛏ | 8/10 | 7/9 | 24 | 54 | 0.01 | 0.00 | 0.03 | 0.01 | 9.7E-03 | ||
Gammaproteobacteria | Gammaproteobacteria | Oceanospirillales | Halomonadaceae | Halomonasᛏ | 10/10 | 7/9 | 22 | 32 | 0.01 | 0.00 | 0.02 | 0.00 | 2.5E-02 | |
Bacteroidetes | Becteroidia | Bacteroidales | Porphyromonadaceae | Barnesiellaᛎ | 10/10 | 7/9 | 3437 | 1319 | 1.74 | 0.27 | 0.69 | 0.38 | 8.8E-03 |
List of significantly (adj. p-value <0.05) increased or decreased abundance of bacteria at multiple taxonomic ranks when comparing infected with uninfected samples at the given time points. Data are illustrated with the prevalence for each given bacteria, absolute counts, and relative abundance. Significantly increased or decreased bacterial groups are depicted in bold letters with up- or down arrows, respectively. Statistics were performed using metagenomeSeq[46].
Results
Chronic T. muris Infection Induces Major Changes in the Gut Microbiota
To examine whether chronic T. muris infection affects the composition of the intestinal microbiota, we infected male C57BL/6 mice with a low dose of T. muris eggs by oral gavage, and collected faecal samples at various time points after infection, coinciding with the different larval developmental stages (S1 Fig). Five weeks after infection, the experiment was terminated and the caecum and colon contents were collected. To confirm the chronic nature of the infection, we assessed the intestinal worm burden of a parallel group of mice infected at the same time. As expected, none of the mice had cleared the infection after five weeks, harbouring 20 ± 3 worms (mean ± SD; n = 5) and were thus, by definition, chronically infected.
Next, we investigated the composition of the intestinal microbiota utilising 16S rRNA gene-based sequencing and found that chronic T. muris-infection induced clear changes in microbial communities of the large intestine (Fig 1). While minor alterations were seen at early time points after infection, the first substantial microbial changes appeared from day 20 (Fig 1 and S2 Fig and S1 Table for statistical summary). The changes became more pronounced with time (Fig 1 and S2 Fig and S3 Fig) and were very distinct at day 35 after infection, compared to the uninfected mice (Fig 1 and S2 Fig and S1 Table for statistical summary). The infection had similar effects on the faecal and caecal microbiota (S4 Fig). Importantly, we detected only very minor changes over time in the microbial composition of the uninfected mice (S5 Fig), demonstrating that differences observed in the infected mice reflected infection-dependent changes. Thus, chronic infection with T. muris is associated with pronounced changes in the microbiota.
Chronic T. muris Infection Decreases Alpha and Gamma, but Increases Beta Diversity of the Microbiota
In order to examine whether chronic T. muris infection influenced the diversity of the intestinal microbiota we determined alpha (within sample) and beta (between samples) diversity for each sample and group, respectively. Alpha diversity analysis was performed on unfiltered data using Shannon index (Fig 2A). The alpha diversity of the faecal samples from the infected mice was significantly decreased after 27 days of infection, and even further decreased after 35 days, while no decrease was observed in the uninfected mice. Similarly, a significant decrease in the alpha diversity in caecal samples was evident after 35 days of infection (Fig 2A). By contrast, beta diversity between the faecal samples from the infected mice was increased after 27 and 35 days, and similarly, increased beta diversity was observed in caecal samples after 35 days (Fig 2B). We therefore investigated whether there was an overall gain or loss of diversity by examining the combined microbiota from all infected mice (gamma diversity) compared to all the uninfected mice. Thus, all untrimmed data were pooled according to treatment and the gamma diversity (between groups) of the infected and uninfected pools was compared using the Shannon index. In accordance with the alpha diversity, we found a decline in gamma diversity at day 27 and 35 after infection in the faecal samples and at day 35 for the caecal samples (S6 Fig). Together, these data demonstrate that chronic T. muris infection causes an overall decrease in microbial diversity of the large intestine.
T. muris Infection Alters the Composition of the Faecal and Caecal Microbiota
Next, we examined the alterations in intestinal microbial composition following T. muris infection by taking taxonomical classifications of operational taxonomic units (OTU) into account. At the phylum level, T. muris infection led to increased abundance of Firmicutes (day 27 and 35) and Proteobacteria (day 35) while decreasing Bacteroidetes (day 27 and 35) in the faecal samples (p<0.05, repeated-measures ANOVA, S7 Fig). Firmicutes, Proteobacteria and Bacteroidetes accounted for more than 90% of the microbiota at all time points. The T. muris infection increased the relative abundance of Firmicutes in faecal samples from 37 ± 3% to 43 ± 6% between day 0 and 35. Likewise, the caecal samples from the infected mice contained 58 ± 6% Firmicutes at day 35 compared to 30 ± 2% and 36 ± 2% in the uninfected mice sacrificed at day 0 and 35, respectively. Proteobacteria and Bacteroidetes are traditionally lipopolysaccharide-containing gram-negative bacteria whereas Firmicutes are, with minor exceptions, gram-positive bacteria, thus, the microbiota was characterised by an increased proportion of gram-positive bacteria after infection due to the increase in Firmicutes.
To further investigate the changes in the microbiota composition following the T. muris infection, we analysed the microbiota composition in a taxa summary plot on family level (Fig 3), statistical analysis on multiple taxonomic ranks (Table 1), heat-mapping at genus level, including hierarchical cluster analysis (Fig 4), and phylogenetic tree analysis to identify candidates at species level (S8 Fig). Hierarchical cluster analysis of Bray-Curtis dissimilarity indices identified day 0 and day 13 to be the most similar, with day 20 as the closest relative, while day 27 and 35 were distinctly clustered on two separated branches (Fig 4), indicating that major changes in the microbiota occurred from day 20 after the infection with T. muris.
Using metagenomeSeq [46] we identified bacteria that were significantly altered due to infection at any given time point. We focused on the most common effects of the infection, which we defined as affected taxa detected in at least as many or more samples compared to the median of the estimated effective sample size, as calculated by MetagenomeSeq. With an increase at day 13 after infection, Bifidobacterium was identified as the only significantly affected genus before the major changes to the microbiota occurring at day 20 and onward (Table 1). The most notable change observed was an increase in the relative abundance of the bacterial family Lactobacillaceae that remained relatively unaltered until day 20, after which it gradually increased in abundance from <5% between day 0 and 20, to 11% and 15% after days 27 and 35, respectively (Table 1 and Fig 3). While the increase in Lactobacillaceae occurred in 8 out of 9 mice, other changes were less general (S9 Fig), further illustrating the variability between individual mice as reflected by the increase in beta diversity described earlier. Interestingly, some genera were affected only at certain time points after infection and then remained stable (Fig 4 and Table 1). Among these we detected an increase in the relative abundance of Alistipes and Odoribacter from the Bacteroidales family at day 20, as well as a decrease in Allobaculum and Barnesiella and a sharp increase in Parasutterella at day 35 (Fig 4 and Table 1). The abundance of Lactobacillus, Allobaculum and Barnesiella were also found to be significantly affected in the caecal samples by the infection with the addition of a >10-fold increased abundance of Mucispirillum and a decrease of the low-abundant Sporobacter selectively in the caecal samples (S2 Table).
By phylogenetic tree analysis, comparing the representative sequences for the OTUs classified within each family and 16S rRNA gene sequences downloaded from the Ribosomal Database Project[50], we identified candidate species for the Lactobacillaceae family affected by T. muris infection. A single OTU (L#1 in S8 Fig) accounted for more than 80% of the relative abundance in faecal samples 35 days after infection, the sequence of which was identical to that of L. apodemi, L. murinus and L. animalis (S8 Fig). The second most abundant OTU was identical to L. gasseri and L. taiwanensis. The same OTUs and similar relative abundance within families were found for caecal samples (data not shown).
A Skewed Intestinal Regulatory/Inflammatory T Cell Balance is Induced upon Chronic T. muris Infection
Finally, we wanted to investigate whether the profound changes observed in the microbiota composition correlated with infection-driven responses in the intestinal immune compartment, which could indicate a potential causal link between these processes. CD4+ T cells are crucial effector cells during acute T. muris infections. At low doses of infection both CD4+ and CD8+ T cells polarise into IFN-γ-secreting effector cells, resulting in the host being unable to expel the worms[53]. In order to confirm that the low infection dose resulted in induction of a Th1 response we therefore tracked and profiled the accumulation of adaptive immune cells in the large-intestinal lamina propria (LI LP) and draining mesenteric lymph nodes (MLN) following chronic T. muris infection. Initial experimentation indicated that there were substantial changes to the intestinal immune system at day 35 after infection, leading us to conduct an additional experiment, with analysis at key time points concurrent with the kinetics of the observed alterations in the microbiota. Moreover given the established capacity of certain bacterial species[54–56], as well as some parasites[57, 58], to promote induction of regulatory T cells (Treg), we also assessed the generation of these cells during chronic T. muris infection.
As expected, mice chronically infected with T. muris developed intestinal inflammation with an accumulation of haematopoietic cells, both in the LI LP (Fig 5A) and MLN (S10A Fig). This was apparent at day 20 and persisted throughout the course of infection. Similarly, the proportion of CD4+ T cells in the LI LP was also increased at day 20 and remained stable with time (Fig 5B), with a similar trend for CD8+ T cells (S10B Fig). In order to investigate potential driving forces from the microbiota on the nature of the adaptive immune response after infection, we focused our analysis on time points either prior to (at day 20) or after (at day 35) the major alterations observed in microbial communities, most notably the Lactobacillaceae. Consistent with our expectations, a large fraction of the total CD4+ T cells in the LI LP expressed classical markers of inflammatory Th1 cells; the cytokine IFN-γ (Fig 5C and 5D) and the transcriptional regulator T-bet (S10C Fig) after infection. The Th1 response was established early after infection (at latest day 20) but interestingly abated as T. muris reached adulthood (Fig 5C). CD8+ T cells, although fewer in numbers relative to CD4+ T cells, were also positive for IFN-γ and T-bet to a similar extent (S10D Fig). Consistent with the T cell response, single-cell suspensions of both LI LP (Fig 5E) and MLN (S10E Fig) from infected mice showed a dramatic IFN-γ secretion upon stimulation with T. muris-derived excretory/secretory (E/S) antigens. Moreover, we detected a slight induction of FoxP3+ Tregs in the MLN as the infection progressed (S10F Fig). However, contrary to what has been reported in other parasite models, we did not detect an increased proportion of FoxP3+ CD4+ T cells in the LI LP at this infection dose, but rather a substantial decrease (Figs 5D and 5F), a change that was apparent already at day 20 and remained as the infection progressed (Fig 5F). Strikingly, the ratio between regulatory and inflammatory CD4+ T cells was reduced almost 16-fold in the LI LP as a consequence of infection (Fig 5G). Treg cells were not only fewer in proportion, but also seemed less prone to produce interleukin-10 (IL-10) at day 35 (Fig 5H and S10C Fig), a cytokine known to be involved in tolerogenic and anti-inflammatory responses. In fact, most of the T cell-derived IL-10 during infection was produced by FoxP3- IFN-γ+ cells (Fig 5D and S10G Fig), and was reflected by IL-10 secretion from E/S-stimulated LI LP cells (S10H Fig). Taken together, these results demonstrate that low dose infection with T. muris led to chronic inflammation of the large intestine, with a decreased ratio between regulatory and inflammatory CD4+ T cells, which was clearly manifested after 20 days of infection and remained as the infection progressed.
Discussion
We have performed a comprehensive study analysing the influence of chronic T. muris infection on the murine gut microbiota using 16S rRNA gene-based sequencing. By infecting mice with T. muris, we have been able to longitudinally study the effect of chronic nematode infection in a highly controlled manner, with sampling at multiple time points. We found that persistent worm infection led to a decrease in bacterial diversity of the large-intestinal microbiota as compared to uninfected mice, with an associated increase in the relative abundance of Lactobacillaceae. In parallel, we detected an overall change in the intestinal regulatory/inflammatory T cell balance following chronic T. muris infection.
Two recent publications describe the effect of T. trichiura infection on the intestinal microbiota of infected humans[38, 39]. Compared with the effects of T. muris infection reported here, the effect of T. trichiura infection in humans appeared less drastic. Cooper et al. found no decrease in the alpha diversity in T. trichiura-infected children compared to an uninfected control group, and similarly no apparent difference was detected following curative treatment[38]. In contrast, Lee et al. detected a minor increase in alpha diversity of the intestinal microbiota in infected individuals, which included combinations of T. trichiura, Ascaris lumbricoides and hookworm co-infections[39]. However apart from likely species-related differences, human field studies are often less controlled compared to laboratory-based studies in mice (e.g. variation in infection dose, duration and timing of infection), and many additional environmental factors will undoubtedly influence the results, e.g. lifestyle, gender, age, hygiene and/or previous pathogen exposure.
We found that chronic T. muris infection had a strong effect on the alpha, beta and gamma diversity of both the faecal and caecal microbiota. The decreased alpha diversity suggests that the microbiota became less diverse within each individual mouse, whereas the concurrent increase in beta diversity illustrates that each individual mouse responded differently to infection, resulting in a larger diversity between the mice. Nevertheless, overall we found the gamma diversity to be decreased, indicating that the total number of different species of bacteria existing in an infected population of mice is reduced compared to an uninfected population. Besides parasite infection, a reduced microbial diversity has been observed in patients suffering from IBD[59], indicating that this phenomenon may be a by-product of the inflammatory process itself rather than being a specific outcome of the parasite infection. On the other hand, Toxoplasma gondii infection was recently found to induce antigen- as well as commensal-specific T cell responses[60]; it is therefore conceivable that T. muris infection per se also results in bacteria-specific responses, which may be driving at least some of the observed changes.
It remains to be established what drives the pronounced and significant changes in the composition of the intestinal microbiota, especially those occurring from day 20 after infection. Several possibilities can be envisaged, which may involve direct as well as indirect mechanisms via the immune system. The time point for the major changes observed in microbial composition coincides with the larvae progressing from the L2 to the L3 developmental stage, a transition that is associated with the worms increasing in size and starting to protrude from the syncytial tunnels into the intestinal lumen. Thus, the physical presence of larvae in the intestinal lumen may be associated with a larger influence on the intestinal environment that may alter the intestinal microbiota. Coincidentally, the parasite may influence its microenvironment by secreting effector molecules that affect the microbiota directly or indirectly via stimulation of host immune cells. A large fraction of the E/S components secreted by the parasite during infection is made up of serine proteases that have a documented capacity to degrade the major intestinal mucin, muc2[61]. Given that many of the intestinal microbes actively attach to the mucous layer it is plausible that the worms, by affecting the integrity of the mucous layer in order to promote their own survival in the intestine, may indirectly also affect the capacity of mucous-adhering bacteria to remain in their intestinal niche[62]. In fact, consistent with such a mechanism, a recent study showed that immune-driven alterations to goblet cell-mediated mucous production led to reduced bacterial attachment to the mucous during T. trichiura infection in macaques[63]. Finally, there are indications that the parasite itself may be driving the changes to the microbiota independent of the adaptive immune response. Along these lines, Rausch et al. found that mice infected with the hookworm Heligmosomoides polygyrus responded with a Th2 response and had altered intestinal microbiota composition[10]. However following infection of IL-4Rα-/- mice, which are compromised in their capacity to generate a Th2 response, they found similar changes in the gut microbiota composition, indicating that the hookworm was able to alter the microbiota independently of the IL-4-regulated adaptive Th2 response[10].
The most notable change of the microbiota following the T. muris infection was an increased abundance of the gram-positive, facultative anaerobic family Lactobacillaceae, suggesting a positive correlation between these bacteria and the nematode infection. This is in agreement with Walk et al, who found the abundance of the Lactobacillus genus to be increased following infection with H. polygyrus, and speculated that the increase in lactobacilli could be an immune-modulating effect of H. polygyrus infection as part of a mutualistic relationship with the resident bacteria[11]. Moreover, Reynolds et al. identified the species L. taiwanensis to be increased by H. polygyrus infection, and showed that administration of L. taiwanensis to BALB/c mice facilitated subsequent infection with the nematode[64]. Furthermore, Dea-Ayuela et al. found that treating mice orally with either viable or dead L. casei enhanced the susceptibility of B10Br mice to T. muris infection[34], and that viable L. casei abrogated the IFN-γ response in MLN after infection. We found a similarly decreased IFN-γ response in both the LI LP and MLN between day 20 to 35, concurrent with an increase in relative abundance of lactobacilli, indicating a possible negative correlation between the IFN-γ response and the presence of lactobacilli. Taken together, this may indicate that the increase in lactobacilli during infection is a process that favours the survival of T. muris, and vice versa, lending credence to the mutualism hypothesis.
Despite prior studies having demonstrated that the microbiota can influence the development and function of the host’s immune system, we detected little correlation between the kinetics of microbial changes and the development of the adaptive immune response. Treg cells play a critical role in controlling immune responses toward both pathogens and the gut microbiota[65], as well as preventing autoimmunity[66]. Furthermore, some parasitic infections are known to induce Treg cells that dampen effector responses[57, 58], in part serving as the rationale for therapeutic worm infection as treatment for human diseases. Our data suggests that this does not seem to be the case for chronic T. muris infection. Rather, the infection drastically reversed the regulatory/inflammatory balance of the intestinal immune system, with the ratio of regulatory to inflammatory T cells going from ∼4:1 in uninfected mice to ∼1:4 following infection. These findings are surprising also given the documented ability of several Lactobacillus species to promote the induction or expansion of Treg cells in various tissues, under different conditions, including parasite infection[64, 67–69]. The change in the balance between regulatory/inflammatory cells was established at an early time point after infection, prior to the observed increase in Lactobacillaceae, and remained relatively stable over time, leading us to conclude that other mechanisms control the differentiation and development of the adaptive immune response. We cannot however rule out that the altered microbiota may influence on the immune response at later stages of the infection.
The Treg cells in our experiments appeared less prone to produce IL-10 as the infection progressed. Nonetheless, we did observe an early burst in IL-10 production by FoxP3- IFN-γ+ cells, possibly as a compensatory mechanism. However, this also abated with time, as did production of IFN-γ+ and the inflammatory response in general. It is therefore possible that T. muris causes immune exhaustion at later stages of chronic infection. Together, this implies a strategy adopted by the immune system to prevent pathology rather than a direct mechanism by the worm to prevent expulsion, as expulsion cannot take place at these low doses without immune intervention, such as blockade of IFN-γ. It is important to note however that these findings only apply to low dose infections. High dose infections are cleared within 2–3 weeks in most mouse strains [70], and it is possible that Treg cell induction occurs by a different kinetic and plays a different role under these conditions.
In summary, our data demonstrate that chronic infection with the nematode T. muris results in an altered intestinal microbiota as well as a perturbed immune regulatory/inflammatory balance. Our results are largely consistent and complementary to those of Houlden et al. published simultaneously to this paper[71], highlighting the reliability of our findings. These studies are of fundamental importance and considerable relevance, especially given the high incidence of worm infections worldwide and current efforts to use parasitic nematodes to ameliorate disorders associated with perturbations in the immune system.
Supporting Information
Acknowledgments
The technical assistance of Marianne Knudsen (University of Copenhagen) is greatly acknowledged.
Data Availability
All sequence data is available from the European Nucleotide Archive (ENA) with study accession number: PRJEB6560. Immunological raw data is available from Dryad Digital Repository (doi:10.5061/dryad.md0vg).
Funding Statement
This work was supported by grants from the Novo Nordisk Foundation (www.novonordiskfonden.dk), The Carlsberg Foundation (www.carlsbergfondet.dk), and the Swedish Medical Research Council (www.vr.se). Yuliaxis Ramayo-Caldas was funded by the European Union, in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship (under grant agreement n° 267196; www.agreenskills.eu). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Sommer F, Backhed F. The gut microbiota—masters of host development and physiology. Nature reviews Microbiology. 2013;11(4):227–38. 10.1038/nrmicro2974 [DOI] [PubMed] [Google Scholar]
- 2. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242–9 10.1038/nature11552 [DOI] [PubMed] [Google Scholar]
- 3. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(44):15718–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Current opinion in microbiology. 2013;16(3):246–54. 10.1016/j.mib.2013.07.002 [DOI] [PubMed] [Google Scholar]
- 5. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122(1):107–18. [DOI] [PubMed] [Google Scholar]
- 6. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–73. 10.1126/science.1223490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–98. 10.1016/j.cell.2009.09.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infection and immunity. 2012;80(11):3786–94. 10.1128/IAI.00647-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science. 2012;336(6086):1325–9. 10.1126/science.1222195 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Rausch S, Held J, Fischer A, Heimesaat MM, Kuhl AA, Bereswill S, et al. Small intestinal nematode infection of mice is associated with increased enterobacterial loads alongside the intestinal tract. PloS one. 2013;8(9):e74026 10.1371/journal.pone.0074026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Walk ST, Blum AM, Ewing SA, Weinstock JV, Young VB. Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflammatory bowel diseases. 2010;16(11):1841–9. 10.1002/ibd.21299 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(34):13780–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Callender JE, Grantham-McGregor S, Walker S, Cooper ES. Trichuris infection and mental development in children. Lancet. 1992;339(8786):181 [DOI] [PubMed] [Google Scholar]
- 14. Nokes C, Grantham-McGregor SM, Sawyer AW, Cooper ES, Bundy DA. Parasitic helminth infection and cognitive function in school children. Proceedings Biological sciences / The Royal Society. 1992;247(1319):77–81. [DOI] [PubMed] [Google Scholar]
- 15. Hewitson JP, Grainger JR, Maizels RM. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Molecular and biochemical parasitology. 2009;167(1):1–11. 10.1016/j.molbiopara.2009.04.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42; quiz e30. 10.1053/j.gastro.2011.10.001 [DOI] [PubMed] [Google Scholar]
- 17. Kondrashova A, Seiskari T, Ilonen J, Knip M, Hyoty H. The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2013;121(6):478–93. 10.1111/apm.12023 [DOI] [PubMed] [Google Scholar]
- 18. Kramer A, Bekeschus S, Broker BM, Schleibinger H, Razavi B, Assadian O. Maintaining health by balancing microbial exposure and prevention of infection: the hygiene hypothesis versus the hypothesis of early immune challenge. The Journal of hospital infection. 2013;83 Suppl 1:S29–34. 10.1016/S0195-6701(13)60007-9 [DOI] [PubMed] [Google Scholar]
- 19. Saunders KA, Raine T, Cooke A, Lawrence CE. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infection and immunity. 2007;75(1):397–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite immunology. 1999;21(4):169–76. [DOI] [PubMed] [Google Scholar]
- 21. McSorley HJ, O'Gorman MT, Blair N, Sutherland TE, Filbey KJ, Maizels RM. Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus. European journal of immunology. 2012;42(10):2667–82. 10.1002/eji.201142161 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Ferreira I, Smyth D, Gaze S, Aziz A, Giacomin P, Ruyssers N, et al. Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis. Infection and immunity. 2013;81(6):2104–11. 10.1128/IAI.00563-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr., Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. European journal of immunology. 2004;34(10):2690–8. [DOI] [PubMed] [Google Scholar]
- 24. Smith P, Mangan NE, Walsh CM, Fallon RE, McKenzie AN, van Rooijen N, et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol. 2007;178(7):4557–66. [DOI] [PubMed] [Google Scholar]
- 25. Bager P, Arnved J, Ronborg S, Wohlfahrt J, Poulsen LK, Westergaard T, et al. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. The Journal of allergy and clinical immunology. 2010;125(1):123–30 e1-3. 10.1016/j.jaci.2009.08.006 [DOI] [PubMed] [Google Scholar]
- 26. Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, et al. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Science translational medicine. 2010;2(60):60ra88. 10.1126/scitranslmed.3001007 [DOI] [PubMed] [Google Scholar]
- 27. Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD, et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler. 2011;17(6):743–54. 10.1177/1352458511398054 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Summers RW, Elliott DE, Urban JF Jr., Thompson R, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut. 2005;54(1):87–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Weinstock JV, Elliott DE. Translatability of helminth therapy in inflammatory bowel diseases. International journal for parasitology. 2013;43(3–4):245–51. 10.1016/j.ijpara.2013.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Cenit MC, Matzaraki V, Tigchelaar EF, Zhernakova A. Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochimica et biophysica acta. 2014. [DOI] [PubMed]
- 31. Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasites & vectors. 2014;7:37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Else KJ, Hultner L, Grencis RK. Cellular immune responses to the murine nematode parasite Trichuris muris. II. Differential induction of TH-cell subsets in resistant versus susceptible mice. Immunology. 1992;75(2):232–7. [PMC free article] [PubMed] [Google Scholar]
- 33. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. The Journal of experimental medicine. 1994;179(1):347–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Dea-Ayuela MA, Rama-Iniguez S, Bolas-Fernandez F. Enhanced susceptibility to Trichuris muris infection of B10Br mice treated with the probiotic Lactobacillus casei. International immunopharmacology. 2008;8(1):28–35. [DOI] [PubMed] [Google Scholar]
- 35. Hayes KS, Bancroft AJ, Goldrick M, Portsmouth C, Roberts IS, Grencis RK. Exploitation of the intestinal microflora by the parasitic nematode Trichuris muris. Science. 2010;328(5984):1391–4. 10.1126/science.1187703 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Li RW, Wu S, Li W, Navarro K, Couch RD, Hill D, et al. Alterations in the porcine colon microbiota induced by the gastrointestinal nematode Trichuris suis. Infection and immunity. 2012;80(6):2150–7. 10.1128/IAI.00141-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Wu S, Li RW, Li W, Beshah E, Dawson HD, Urban JF Jr. Worm burden-dependent disruption of the porcine colon microbiota by Trichuris suis infection. PloS one. 2012;7(4):e35470 10.1371/journal.pone.0035470 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Cooper P, Walker AW, Reyes J, Chico M, Salter SJ, Vaca M, et al. Patent human infections with the whipworm, Trichuris trichiura, are not associated with alterations in the faecal microbiota. PloS one. 2013;8(10):e76573 10.1371/journal.pone.0076573 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Lee SC, Tang MS, Lim YA, Choy SH, Kurtz ZD, Cox LM, et al. Helminth colonization is associated with increased diversity of the gut microbiota. PLoS neglected tropical diseases. 2014;8(5):e2880 10.1371/journal.pntd.0002880 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Wakelin D. Acquired immunity to Trichuris muris in the albino laboratory mouse. Parasitology. 1967;57(3):515–24. [DOI] [PubMed] [Google Scholar]
- 41. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 2010;7(5):335–6. 10.1038/nmeth.f.303 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Applied and environmental microbiology. 2013;79(17):5112–20. 10.1128/AEM.01043-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460–1. 10.1093/bioinformatics/btq461 [DOI] [PubMed] [Google Scholar]
- 44. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied and environmental microbiology. 2006;72(7):5069–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and environmental microbiology. 2007;73(16):5261–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Paulson JN, Stine OC, Bravo HC, Pop M. Differential abundance analysis for microbial marker-gene surveys. Nature methods. 2013;10(12):1200–2. 10.1038/nmeth.2658 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PloS one. 2013;8(4):e61217 10.1371/journal.pone.0061217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Oksanen J BF, Kindt R, Legendre P, O'Hara RB. Vegan: Community Ecology Package. R package version 1.17–10. 2011.
- 49. Wickham H. Ggplot2: elegant graphics for data analysis New York: Springer; 2009. viii, 212 p. p. [Google Scholar]
- 50. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic acids research. 2014;42(Database issue):D633–42. 10.1093/nar/gkt1244 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic acids research. 2004;32(5):1792–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Molecular biology and evolution. 1993;10(3):512–26. [DOI] [PubMed] [Google Scholar]
- 53. Humphreys NE, Worthington JJ, Little MC, Rice EJ, Grencis RK. The role of CD8+ cells in the establishment and maintenance of a Trichuris muris infection. Parasite immunology. 2004;26(4):187–96. [DOI] [PubMed] [Google Scholar]
- 54. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337–41. 10.1126/science.1198469 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232–6. 10.1038/nature12331 [DOI] [PubMed] [Google Scholar]
- 56. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity. 2011;34(5):794–806. 10.1016/j.immuni.2011.03.021 [DOI] [PubMed] [Google Scholar]
- 57. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, Filbey KJ, et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. The Journal of experimental medicine. 2010;207(11):2331–41. 10.1084/jem.20101074 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. McSorley HJ, Harcus YM, Murray J, Taylor MD, Maizels RM. Expansion of Foxp3+ regulatory T cells in mice infected with the filarial parasite Brugia malayi. J Immunol. 2008;181(9):6456–66. [DOI] [PubMed] [Google Scholar]
- 59. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–99. 10.1053/j.gastro.2014.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Hand TW, Dos Santos LM, Bouladoux N, Molloy MJ, Pagan AJ, Pepper M, et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science. 2012;337(6101):1553–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Hasnain SZ, McGuckin MA, Grencis RK, Thornton DJ. Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier. PLoS neglected tropical diseases. 2012;6(10):e1856 10.1371/journal.pntd.0001856 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Van den Abbeele P, Van de Wiele T, Verstraete W, Possemiers S. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS microbiology reviews. 2011;35(4):681–704. 10.1111/j.1574-6976.2011.00270.x [DOI] [PubMed] [Google Scholar]
- 63. Broadhurst MJ, Ardeshir A, Kanwar B, Mirpuri J, Gundra UM, Leung JM, et al. Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS pathogens. 2012;8(11):e1003000 10.1371/journal.ppat.1003000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Reynolds L, Smith K, Filbey K, Harcus Y, Hewitson J, Redpath S, et al. Commensal-pathogen interactions in the intestinal tract: Lactobacilli promote infection with, and are promoted by, helminth parasites. Gut microbes. 2014;5(4). 10.4161/gmic.32130 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Bollrath J, Powrie FM. Controlling the frontier: regulatory T-cells and intestinal homeostasis. Seminars in immunology. 2013;25(5):352–7. 10.1016/j.smim.2013.09.002 [DOI] [PubMed] [Google Scholar]
- 66. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28(4):546–58. 10.1016/j.immuni.2008.02.017 [DOI] [PubMed] [Google Scholar]
- 67. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. American journal of respiratory and critical care medicine. 2009;179(3):186–93. 10.1164/rccm.200806-951OC [DOI] [PubMed] [Google Scholar]
- 68. Kim HJ, Kim YJ, Kang MJ, Seo JH, Kim HY, Jeong SK, et al. A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus. Experimental dermatology. 2012;21(9):672–5. 10.1111/j.1600-0625.2012.01539.x [DOI] [PubMed] [Google Scholar]
- 69. Jang SO, Kim HJ, Kim YJ, Kang MJ, Kwon JW, Seo JH, et al. Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells. Allergy, asthma & immunology research. 2012;4(3):150–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Cliffe LJ, Grencis RK. The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection. Advances in parasitology. 2004;57:255–307. [DOI] [PubMed] [Google Scholar]
- 71.Houlden A, Hayes KS, Bancroft AJ, Worthington JJ, Wang P, Grencis RK, et al. Chronic Trichuris muris infection in C57BL/6 mice causes significant changes in host microbiota and metabolome: effects reversed by pathogen clearance. PLoS ONE. [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All sequence data is available from the European Nucleotide Archive (ENA) with study accession number: PRJEB6560. Immunological raw data is available from Dryad Digital Repository (doi:10.5061/dryad.md0vg).